Your Journey to Becoming Inspection Ready
It is well known that building and maintaining a culture of quality is crucial to the success of a clinical trial, but how can you be sure that your methods are best practice?
The GCP Inspection Readiness forum will guide you on your journey to becoming inspection ready. Join like minded peers as you engage in high levels of interactivity and overcome your challenges in: creating a culture of quality, sponsor oversight, CAPAs, QMS and understanding the regulatory landscape. Complete your journey with our onsite mock-inspection where you will give your new skills a trial run and leave with the confidence, you are inspection ready.
As the only European forum where Clinical Quality and Operations Professionals join together in collaboration to benchmark with their peers in Big Pharma, SMEs and CROs, the GCP Inspection Readiness forum will give you the practical solutions you have been looking for.
Head of TMF & Registry Operations, Clinical Development Quality, Global Product Development
Sr Auditor, Quality Assurance
Quality Planning & Strategy (QP&S) Trial Oversight Specialist. Johnson & Johnson and (Former Scientific Officer at EMA Inspection Sector)
Johnson & Johnson
Chairman of the Board of Directors
Director GCP Compliance, Global QA, Development
Director Regional Compliance
Chairman of the Board of Directors
Institute of Clinical Research
Senior Director Quality Strategy
Global GxP QMS Manager, Global Quality Assurance
Head Clinical Quality Assurance
Clinical Quality Auditor
Good Clinical Practice Alliance – Europe & Strategic Initiative for Developing Capacity in Ethical Review
Senior Safety Specialist, Global Medical Affairs, Clinical, Scientific & Medical Affairs, Global R&D
Smith & Nephew
Clinical Risk Management Lead
Quality Assurance Advisor
Your Complete Journey to Inspection Readiness
Manage Inspector Expectations by Understanding Global Regulations, with insights from bluebird bio, Johnson & Johnson and Smith & Nephew
Perfect your risk management strategy personalised to your company with case studies from Pfizer, Pierre Fabre and UCB sharing their experiences
Streamline your approach to Good Clinical Practice by ensuring your electronic systems are up to scratch, as Grünenthal and Ferring give you their top tips
Re-imagine your strategy for sponsor oversight and transform the collaborative relationship, by hearing directly from PPD and Polpharma on how they maintain transparency and take ownership of quality
Safeguard your clinical trial by understanding the principles of data integrity with expert guidance from the Good Clinical Practice Alliance and the Health Sciences Records and Archives Association
Finish Point: All –Day Mock Inspection: Put your new skills to the test and leave with the confidence you ARE inspection ready! Exploring the latest case studies from Roche and Grünenthal
With recent changes amongst GCP Guidelines, including the amendment of ICH E6 it is now more critical than ever to keep up to date and ensure a culture of readiness. View this checklist to help you on your journey to compliance and maintain a culture of quality.
Blog: Journey to Inspection Readiness
It is well known that building and maintaining a culture of quality is crucial to the success of a clinical trial, but how can you be sure that your methods are consistent and best practice? Find out how you can curate a consistent culture of readiness in your organisation here.